CMPK1 and non-small cell lung carcinoma: Likewise, our clinical data showed that NSCLC patients with low miR‐302e or high circ‐CMPK1 expression had shorter survival time than those with high miR‐302e or low circ‐CMPK1 expression, revealing that miR‐302e or circ‐CMPK1 may be a potential prognostic predictor for patients with NSCLC.